Inventage Lab, Inc. (389470.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
20,550.00 KRW
Market cap
272.85 bn KRW
P/E (2025)
–
P/S (2025)
92.84
Dividend yield
0.00 %
Net margin
-287.82 %
Return on equity (ROE)
-10.46 %
Return on assets (ROA)
-7.64 %

Inventage Lab, Inc. financials

Fiscal year20242025
Revenue1.78 bn KRW2.94 bn KRW
Gross profit1.75 bn KRW-2.94 bn KRW
Operating income-18.96 bn KRW-28.38 bn KRW
EBIT-17.04 bn KRW-9.55 bn KRW
Net income-17.00 bn KRW-8.46 bn KRW
Diluted EPS – continuing operations-1,692.03 KRW–

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Inventage Lab, Inc.

Inventage Lab, Inc., a platform technology company, develops medicines using microfluidics-based drug delivery systems. The company was founded in 2015 and is based in Seongnam-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.